Business Combinations (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Business Combination [Line Items] |
|
| Schedule of Estimated Useful Lives of Identifiable Intangible Assets Acquired |
Estimated useful lives of the identifiable intangible assets acquired are as follows:
|
|
|
|
|
Useful Life |
Customer relationships |
|
7 years |
Trade names |
|
7 years |
Developed technology - software |
|
3 years |
Developed technology - biotech |
|
5 years |
|
| Paige.AI, Inc. [Member] |
|
| Business Combination [Line Items] |
|
| Summarizes the Allocation of Aggregate Purchase Price |
The following table summarizes the allocation of the aggregate purchase price of the Paige Acquisition (in thousands):
|
|
|
|
|
Assets |
|
|
|
Cash |
|
$ |
2,851 |
|
Accounts receivable |
|
|
761 |
|
Prepaid expenses and other current assets |
|
|
5,011 |
|
Total current assets |
|
$ |
8,623 |
|
Property and equipment, net |
|
|
1,116 |
|
Operating lease right-of-use assets |
|
|
7,968 |
|
Investments and other assets |
|
|
240 |
|
Restricted cash |
|
|
2,870 |
|
Total assets acquired |
|
$ |
20,817 |
|
|
|
|
|
Liabilities |
|
|
|
Accounts payable |
|
$ |
538 |
|
Accrued expenses |
|
|
3,849 |
|
Operating lease liabilities |
|
|
1,887 |
|
Deferred revenue |
|
|
238 |
|
Total current liabilities |
|
$ |
6,513 |
|
Deferred revenue, less current portion |
|
|
908 |
|
Operating lease liabilities, less current portion |
|
|
13,058 |
|
Other long-term liabilities |
|
|
39,951 |
|
Total liabilities assumed |
|
$ |
60,430 |
|
|
|
|
|
Net assets acquired and liabilities assumed |
|
$ |
(39,613 |
) |
Goodwill |
|
$ |
141,130 |
|
|
|
|
|
Cash consideration |
|
$ |
2,983 |
|
Stock consideration |
|
|
98,534 |
|
Total acquisition price |
|
$ |
101,517 |
|
|
| Ambry [Member] |
|
| Business Combination [Line Items] |
|
| Summarizes the Allocation of Aggregate Purchase Price |
The following table summarizes the allocation of the aggregate purchase price of the Ambry Acquisition (in thousands):
|
|
|
|
|
Assets |
|
|
|
Cash |
|
$ |
20,555 |
|
Accounts receivable |
|
|
62,853 |
|
Inventory |
|
|
11,188 |
|
Prepaid expenses and other current assets |
|
|
10,153 |
|
Total current assets |
|
$ |
104,749 |
|
Property and equipment, net |
|
|
38,560 |
|
Operating lease right-of-use assets |
|
|
26,198 |
|
Investments and other assets |
|
|
268 |
|
Customer relationships |
|
|
234,000 |
|
Trade names |
|
|
33,000 |
|
Developed technology - software |
|
|
18,000 |
|
Developed technology - biotech |
|
|
114,000 |
|
Total assets acquired |
|
$ |
568,775 |
|
|
|
|
|
Liabilities |
|
|
|
Accounts payable |
|
$ |
199 |
|
Accrued expenses |
|
|
28,870 |
|
Operating lease liabilities |
|
|
3,008 |
|
Deferred revenue |
|
|
1,347 |
|
Total current liabilities |
|
$ |
33,424 |
|
Deferred revenue, less current portion |
|
|
1,099 |
|
Operating lease liabilities, less current portion |
|
|
23,259 |
|
Deferred tax liabilities |
|
|
52,917 |
|
Other long-term liabilities |
|
|
368 |
|
Total liabilities assumed |
|
$ |
111,067 |
|
|
|
|
|
Net assets acquired and liabilities assumed |
|
$ |
457,708 |
|
Goodwill |
|
$ |
234,635 |
|
|
|
|
|
Cash consideration |
|
$ |
394,296 |
|
Stock consideration |
|
|
298,047 |
|
Total acquisition price |
|
$ |
692,343 |
|
|
| Schedule of Pro Forma Information |
The following pro forma information shows the results of the Company's operations as though the acquisition had occurred as of the beginning of the comparable period, January 1, 2024 (in thousands):
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2025 |
|
Revenues |
|
$ |
288,660 |
|
Net loss |
|
|
(124,344 |
) |
|